Expert consensus on oral management in autoimmune bullous diseases, erythema multiforme and SJS / TEN
Journal of the European Academy of Dermatology and Venereology · 2026
DOI: 10.1111/jdv.70578 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, 2026. Verfasst von Shalini Nayee und 39 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Medicine, Guy's Hospital, Guy's and St Thomas' NHS Foundation Trust, London, UK. Hauptthemen laut MEDLINE: Erythema Multiforme, Stevens-Johnson Syndrome, Autoimmune Diseases, Mouth Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Reference Network for rare skin diseases (ERN Skin).
Abstract (Originalsprache)
Background
Autoimmune bullous diseases ( AIBD ), Stevens‐Johnson syndrome and toxic epidermal necrolysis ( SJS ‐ TEN ) and erythema multiforme ( EM ) often present with clinically similar features in the oral mucosa: classically widespread mucosal erosions or ulceration. Despite this, there are no formalized guidelines for the specific management of the oral manifestations of these conditions.
Objectives
We sought to establish an consensus on the management of oral involvement of AIBD , SJS ‐ TEN and EM using the Delphi method.
Methods
Participants were sent a survey comprising 62 statements organized into 6 categories: general oral and dental recommendations; disease severity scoring; topical therapies for active oral involvement in AIBD; systemic therapies for active oral involvement in AIBD; additional considerations for inpatient care of AIBD, EM, SJS‐TEN; specific considerations for EM and SJS‐TEN. Participants rated the level of appropriateness of each statement. Results were analysed using the RAND/UCLA Appropriateness Method.
Results
34 experts, primarily Oral Medicine clinicians and Dermatologists, completed the survey. Consensus was achieved for 58 (93.5%) statements after a single round. General recommendations included rigorous oral hygiene and regular dental/periodontal care. Disease‐specific severity scoring was recommended to guide treatment and monitor response. For active oral AIBD, experts recommended moderate‐to‐super potent topical corticosteroids, guided by severity and site of oral disease. For inpatients, supported oral hygiene, regular topical anaesthetics and nutritional support for impaired intake were recommended. For acute EM and SJS‐TEN, recommendations included regular lip care with gentle debridement of haemorrhagic crusts and application of soft paraffin.
Conclusions
This Delphi sets out a broad framework for the management of oral involvement in AIBD, SJS‐TEN and EM, to be adapted by a multidisciplinary team, for both acute and long‐term management of these conditions. It may help to standardize the management of oral manifestations of these conditions in future multicentre studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oral Medicine, Guy's Hospital, Guy's and St Thomas' NHS Foundation Trust, London, UK.
- Dermatology Department, AP-HP, Henri Mondor hospital, Crétil, France.
- Reference center for toxic bullous dermatoses and severe drug reactions TOXIBUL, Créteil, France.
- AIBD-ToxiTEN group of the ERN-skin, Univ Paris Est Créteil, EpiDermE, Créteil, France.
- Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland.
- Department of Dermatology, King's College Hospital, London, UK.
ORCID-Profile: Molly Harte, Saskia Ingen-Housz-Oro, Sarah Walsh, Pascal Joly
Förderung
- European Reference Network for rare skin diseases (ERN Skin)
Zitieren
APA
Nayee, S., Harte, M., Ingen-Housz-Oro, S., Ameri, M., Walsh, S., Joly, P., Ardern-Jones, M., Brailo, V., Brueggen, M. C., Bunker, C., Carey, B., Carrozzo, M., Chua, S. L., Creamer, D., Culton, D., Delli, K., Diniz-Freitas, M., Dodiuk-Gad, R., Dridi, S. M., …, & Setterfield, J. (2026). Expert consensus on oral management in autoimmune bullous diseases, erythema multiforme and SJS / TEN. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.70578
Vancouver
Nayee S, Harte M, Ingen-Housz-Oro S, Ameri M, Walsh S, Joly P, et al. Expert consensus on oral management in autoimmune bullous diseases, erythema multiforme and SJS / TEN. Journal of the European Academy of Dermatology and Venereology. 2026. doi:10.1111/jdv.70578
BibTeX
@article{Nayee2026,
author = {Nayee, Shalini and Harte, Molly and Ingen-Housz-Oro, Saskia and Ameri, Milad and Walsh, Sarah and Joly, Pascal and Ardern-Jones, Michael and Brailo, Vlaho and Brueggen, Marie-Charlotte and Bunker, Christopher and Carey, Barbara and Carrozzo, Marco and Chua, Ser-Ling and Creamer, Daniel and Culton, Donna and Delli, Konstantina and Diniz-Freitas, Marcio and Dodiuk-Gad, Roni and Dridi, Sophie-Myriam and Ejeil, Anne-Laure and French, Lars and Gaspar, Krisztian and Higham, Jon and Horvarth, Barbara and Hullah, Esther and Jurge, Sabine and McMillan, Roddy and McParland, Helen and Murrell, Dedee and Ormond, Martyn and Poveda-Gallego, Ana and Samimi, Mahtab and Schmidt, Enno and Shephard, Martina and Sollecito, Tom and Taylor, Jennifer and Uzun, Soner and Valiukeviciene, Skaidra and Willis, Amanda and Setterfield, Jane},
title = {Expert consensus on oral management in autoimmune bullous diseases, erythema multiforme and SJS / TEN},
journal = {Journal of the European Academy of Dermatology and Venereology},
year = {2026},
doi = {10.1111/jdv.70578}
}
EUVIMED